George Acquaah-Mensah

Professor of Pharmaceutical Sciences

Massachusetts College of Pharmacy and Health Sciences
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Year:

2026

Background/Objectives: Breast cancer (BrCA) is among the deadliest cancers for women in the world. The disease has four distinct molecular subtypes which can be determined by gene expression profiling. Understanding these subtypes has enabled the development of targeted therapeutics. Additionally, following initial successful treatment, some patients experience disease recurrence events. Methods: In this study, we used radiomics coupled with machine learning techniques to predict molecular subtypes and disease recurrence events from a dataset of MRI features deriving from a single-institutional, retrospective collection of 922 biopsy-confirmed invasive BrCA patients. The feature-rich and comprehensive dataset consists of radiomic as well as demographic, clinical, and molecular subtype information. We focused our analyses on Black and White patients who were 50 years or younger at diagnosis (n = 346) to identify racial disparities that exist between molecular subtypes and disease recurrence events. Random Forest and AdaBoostM1 were applied to over 500 radiomics features. Results: Radiomics alone or combined with gene expression data can accurately predict molecular subtype and disease recurrence events for both racial groups. In total, we found over 40 radiomics features that have significant associations with race. The radiomic features that are most predictive in the Breast and Fibroglandular Tissue Volume imaging category for Black patients was breast volume (Breast_Vol) and for White patients was post contrast tissue volume (TissueVol_PostCon). Conclusions: These results suggest that radiomics can be used to predict differences in BrCA recurrence and molecular subtype between racial groups and can have an impact on clinical outcomes.

Year:

2025

Lung cancer, the leading cause of cancer mortality, exhibits diverse histologic subtypes and genetic complexities. Numerous preclinical mouse models have been developed to study lung cancer, but data from these models are disparate, siloed, and difficult to compare in a centralized fashion. In this study, we established the Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB), an extensive repository of 1,354 samples from 77 transcriptomic datasets covering 974 samples from genetically engineered mouse models (GEMM), 368 samples from carcinogen-induced models, and 12 samples from a spontaneous model. Meticulous curation and collaboration with data depositors produced a robust and comprehensive database, enhancing the fidelity of the genetic landscape it depicts. The LCAMGDB aligned 859 tumors from GEMMs with human lung cancer mutations, enabling comparative analysis and revealing a pressing need to broaden the diversity of genetic aberrations modeled in the GEMMs. To accompany this resource, a web application was developed that offers researchers intuitive tools for in-depth gene expression analysis. With standardized reprocessing of gene expression data, the LCAMGDB serves as a powerful platform for cross-study comparison and lays the groundwork for future research, aiming to bridge the gap between mouse models and human lung cancer for improved translational relevance. Significance: The Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB) provides a comprehensive and accessible resource for the research community to investigate lung cancer biology in mouse models.

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (24)

Kekoa Taparra

Assistant Professor

University of California, Los Angeles

UNITED STATES
View details

John Minna

Professor and Direcdtor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Vassilis Aidinis

Biomedical Sciences Research Center Alexander Fleming

GREECE
View details

Barbara Grüner

University Hospital Essen

GERMANY
View details

Phuoc T. Tran

University of Maryland

UNITED STATES
View details

Pawel Mazur

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Roger A. Moorehead

University of Guelph

CANADA
View details

Ralph J. DeBerardinis

University of Texas Southwestern Medical Center

UNITED STATES
View details

Charles Rudin

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

J. Edward van Veen

Assistant Adjunct Professor

University of California, Los Angeles

UNITED STATES
View details

Yonathan Lissanu

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Trudy G. Oliver

Duke University

UNITED STATES
View details

YING GAO

University of Texas Southwestern Medical Center

UNITED STATES
View details

David MacPherson

Professor

Fred Hutch Cancer Center

UNITED STATES
View details

Giorgio Ramadori

Scientific Collaborator

University of Geneva

SWITZERLAND
View details

Rosanna Martinelli

Professor of Molecular Biology

Università degli Studi di Napoli Federico II

ITALY
View details

Min Gyu Lee

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Florian Gnad

Head

Roche Diagnostics

GERMANY
View details

Shyam Biswal

Professor

Johns Hopkins University

UNITED STATES
View details

Arun Pandiri

Staff Scientist

National Institute of Environmental Health Sciences

UNITED STATES
View details

CHARLES POWELL

Division Chief/Professor of Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Jennifer Beane-Ebel

Assistant Professor

Boston University School of Medicine

UNITED STATES
View details

Guanghua Xiao

-

UNITED STATES
View details

Yang Xie

Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details